Health Trials

Advanced Solid Malignant Tumor

1

Review clinical trials related to Advanced Solid Malignant Tumor. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.

This is a Phase 1b/2, single-arm, open-label, dose-escalation study including 2 stages: Phase 1b: Dose-Escalation Stage (Single-Dose and Consecutive-Dose Periods) Phase 2: recommended Phase 2 dose (RP2D) of chiauranib will be given to all patients enrolled in this phase once daily for 28-day cycles continuously with no interruption between cycles.

Participants needed: 36
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Chipscreen Biosciences, Ltd.Updated: Jul 16, 2024Locations: 11
Eligibility criteria

Patient is at least 18 years of age, regardless of gender. Patient has a diagnos... [+9]

Patient has received any systemic anticancer therapy (including chemotherapy, ta... [+22]

Read more